Newsletter | October 31, 2024

10.31.24 -- Is The Downstream Biomanufacturing Bottleneck Over?

FEATURED EDITORIAL

Survey Says Downstream Biomanufacturing Bottleneck Is Over

By Ioanna Deni, BioPlan Associates, Inc.

BioPlan's 21st annual survey finds that downstream processing capacity constraints are at their lowest reported in years.

3 AI Breakthroughs Revolutionizing Pharma Tech Ops At Roche

By Yiming Peng and Margaux Penwarden, Roche

Roche has pushed through so-called "pilot purgatory" and rolled out artificial intelligence solutions in the real world. Two of its data leaders describe three case studies.

INDUSTRY INSIGHTS

Building An Effective Contamination Control Strategy For Final Sterile Filtration

Webinar | Cytiva

Watch to learn about important considerations for final sterile filtration throughout product development and for performing pre-use post-sterilization integrity testing.

NEWS HEADLINES

•

Accord Healthcare Receives Positive CHMP Opinion For IMULDOSA, ustekinumab Biosimilar To Stelara

•

CHMP Recommends The Approval Of Dong-A ST's IMULDOSA, A Biosimilar To Stelara

•

Alvotech And Teva Announce U.S. FDA Approval Of Additional Presentation Of SELARSDI (ustekinumab-aekn), Expanding Its Label To Include Further Indications Approved For Reference Product, Stelara (ustekinumab)

•

AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline Digest;: FDA-Approved Biosimilars Outpaces Cell And Gene Therapy Amid Complex Regulatory Challenges

SOLUTIONS

Drug Characterization And Release Testing Services

Mabion